Murakami M, Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Feb 29:hyae026. Online ahead of print.
Takikawa T, Kikuta K, Sano T, Ikeura T, Fujimori N, Umemura T, Naitoh I, Nakase H, Isayama H, Kanno A, Kamata K, Kodama Y, Inoue D, Ido A, Ueki T, Seno H, Yasuda H, Iwasaki E, Nishino T, Kubota K, Arizumi T, Tanaka A, Uchida K, Matsumoto R, Hamada S, Nakamura S, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP.
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
Pancreatology. 2024 Jan 19:S1424-3903(24)00023-1. Online ahead of print.
Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama S< Takada R, Kobayashi S, Ikeda M, Muwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T, Fujimori N, Ueno M, Ishii H, Furuse J and Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG)
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713. doi: 10.1093/jjco/hyad044.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597. doi: 10.1007/s00535-023-01987-8. Epub 2023 Apr 26.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.
Dig Dis Sci. 2023 Apr;68(4):1139-1147.
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG).
A randomized phase Ⅱ study of modified FOLFIRINOX versus gemcitabine plusnab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Eur J Cancer. 2023 Mar;181:135-144.
Ikenaga N, Nakata K, Abe T, Ideno N, Fujimori N, Oono T, Fujita N, Ishigami K, Nakamura M.
Risks and benefits of pancreaticoduodenectomy in patients aged 80 years and over
Langenbecks Arch Surg. 2023 Feb 27;408(1):108. doi: 10.1007/s00423-023-02843-2.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J, Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet. 2023 Jan 21; 401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4.
Ohno A, Fujimori N, Kaku T, Takamatsu Y, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Hijioka M, Kawabe K, Harada N, Nakamuta M, Aso A, Oono T, Ogawa Y.
Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
Dig Dis Sci. 2022 Dec;67(12):5676-5684. doi: 10.1007/s10620-022-07555-z. Epub 2022 Jun 10.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2022 Dec 7. doi: 10.1111/ajco.13903. Online ahead of print.
Ohno A, Fujimori N, Kaku T, Hijioka M, Kawabe K, Harada N, Nakamuta M, Oono T, Ogawa Y.
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center.
Clin Endosc. 2022 Nov;55(6):784-792. doi: 10.5946/ce.2021.244. Epub 2022 Oct 21.
Shibata K. Motozono C, Nagae M, Shimizu T, Ishikawa E, Motooka D, Okuzaki D, Izumi Y, Takahashi M, Fujimori N, Wing JB, Hayano T, Asai Y, Bamba T, Ogawa Y, Furutani-Seiki Makoto, Shirai M, Yamasaki S.
Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b
Nat Commun. 2022 Nov 14;13(1):6948.doi: 10.1038/s41467-022-34802-8.
Teramatsu K, Oono T, Oyama K, Fujimori N, Murakami M, Yasumori S, Ohno A, Matsumoto K, Takeno A, Nakata K, Nakamura M, Ogawa Y.
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
BMC Cancer. 2022 Nov 4;22(1):1134. doi: 10.1186/s12885-022-10207-0.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T, Furukawa M, Ogawa Y.
Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: A multicenter, prospective observational study.
J Clin Med. 2022 Aug 30;11(17):5084. doi: 10.3390/jcm11175084.
Takamatsu Y, Fujimori N, Miyagahara T, Suehiro Y, Kaku T, Kawabe K, Ohno A, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Oono T, Ogawa Y.
The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction.
Sci Rep. 2022 Jun 13;12(1):9746. doi: 10.1038/s41598-022-13209-x.
Matsumoto K, Fujimori N, Hata Y, Minoda Y, Murakami M, Teramatsu K, Takamatsu Y, Takeno A, Oono T, Ihara E, Nakata K, Nakamura M, Yamamoto T, Koga Y, Oda Y, Ito T, Ogawa Y.
Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Dig Dis. 2022 May 19. doi: 10.1159/000525013. Online ahead of print.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ito T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a singlecenter experience.
Endocr J. 2022 May 27. doi: 10.1507/endocrj.EJ22-0111. Online ahead of print.
Murakami M, Fujimori N, Ohno A, Matsumoto K, Teramatsu K, Takamatsu Y, Takeno A, OonoT, Abe T, Ideno N, Ikenaga N, Nakata K, Nakamura M, Ishigami K, Ogawa Y.
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: A single-center retrospective study.
Discover Oncology, vol13(1) 2022 Jan 3;13(1):2. Doi: 10.1007/s12672-021-00462-1.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7
Okuno H, Ogino H, Ihara E, Nishioka K, Tanaka Y, Chinen T, Kohjima M, Oono T, Tanaka M, Goya T, Fujimori N, Iboshi Y, Gotoda T, Ogawa Y.
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
BMC Gastroenterol. 2021 Feb 16;21(1):73. doi: 10.1186/s12876-021-01656-1.
Fujimori N, Osoegawa T, Aso A, Itaba S, Minoda Y, Murakami M, Matsumoto K, Teramatsu K, Takamatsu Y, Takaoka T, Oono T, Ihara E, Yoshizumi T, Ohtsuka T, Nakamura M, Ogawa Y.
Efficacy of early endoscopic ultrasound-guided transluminal drainage for postoperative pancreatic fistula.
Can J Gastroenterol Hepatol. 25;2021:6691705. eCollection 2021
Minaga K, Takenaka M, Ogura T, Tamura T, Kuroda T, Kaku T, Uenoyama Y, Noguchi C, Nishikiori H, Imai H, Sagami R, Fujimori N, Higuchi K, Kudo M, Chiba Y, Kitano M.
Endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction with surgically altered anatomy: a multicenter prospective registration study.
Therap Adv Gastroenterol. 13:1-11, 2020
Ito T, Fujimori N, Honma Y, Kudo A, Hijioka S, Katsushima S, Kimura Y, Fukutomi A, Hisamatsu S, Nakajima A, Shimatsu A.
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.
Asia Pac J Clin Oncol. 2020 Aug 5. doi: 10.1111/ajco.13371. Online ahead of print.
Masamune A, Kikuta K, Kume K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019.
J Gastroenterol. 55:1062-1071, 2020
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society.
Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016.
Pancreatology. 20:629-636, 2020
Fujimori N, Miki M, Lee L, Matsumoto K, Takamatsu Y, Takaoka T, Teramatsu K, Suehiro Y, Murakami M, Igarashi H, Oono T, Ohtsuka T, Nakamura M, Koga Y, Oda Y, Ito T, Ogawa Y.
Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
Pancreatology. 20:709-715, 2020
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Collaborators.
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
J Gastroenterol. 55:462-470, 2020
Fujita N, Nishie A, Asayama Y, Ishigami K, Fujimori N, Ito T, Honda H
Intravoxel incoherent motion magnetic resonance imaging for assessment of chronic pancreatitis with special focus on its early stage.
Acta Radiol. 61:579-585, 2020
Miki M, Oono T, Fujimori N, Takaoka T, Kawabe K, Miyasaka Y, Ohtsuka T, Saito D, Nakamura M, Ohkawa Y, Oda Y, Suyama M, Ito T, Ogawa Y.
CLEC3A, MMP7, and LCN2 as Novel Markers for Predicting Recurrence in Resected G1 and G2 Pancreatic Neuroendocrine Tumors.
Cancer Med. 8:3748-3760, 2019
Miyasaka Y, Ohtsuka T, Kimura R, Matsuda R, Mori Y, Nakata K, Kakihara D, Fujimori N, Ohno T, Oda Y, Nakamura M.
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.
Ann Surg Oncol. 26:1528-1534, 2019
Miki M, Fujimori N, Oono T, Kawabe K, Ohno A, Matsumoto K, Teramatsu K, Tachibana Y, Ogawa Y.
Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
J Dig Dis. 20:152-158, 2019
Toriyama K, Hijioka S, Komoto I, Kobayashi N, Okusaka T, Ku Y, Sudo K, Furukawa M, Tachibana Y, Takahashi M, Yasuda H, Nakamori S, Honma Y, Kida M, Fujimori N, Kashiwada T, Masui T, Ishii H, Tsuchiya Y, Isaji S, Mizuno N, Hara K, Sakamine M, Imamura M, Kagimura T, Ito T.
Study Protocol for Prospective Observational Study 1 on the Prognosis of Patients with Unresectable Advanced Gastrointestinal and Pancreatic Neuroendocrine Tumors (PROP-UP 1 Study) in Japan.
J Clin Trials Vol 8(4) 2018
Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K, Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.
Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.
Pancreatology. 18; 566-571, 2018
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells.
Biomed Res Int. 87:19397, 2018
Lee L, Ito T, Igarashi H, Miki M, Fujimori N, Kawabe K, Jensen RT, Ogawa Y.
Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.
Cancer Chemother Pharmacol. 81:163-169, 2018
Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Pancreas. 46:476-481, 2017
Niina Y, Ito T, Ueda K, Lee L, Igarashi H, Hijioka M, Takaoka T, Fujiyama T, Miki M, Tachibana Y, Fujimori N, Ohtsuka T, Nakamura K, Kawabe K, Ogawa Y.
Effectiveness of endoscopic duodenal stenting for the management of patients with unresectable pancreatic cancer.
Gastroenterol Hepatol Endosc, 2:1-5, 2017
Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T.
Evidence-based Clinical Practice Guidelines for Chronic Pancreatitis 2015.
J Gastroenterol 51: 85-92, 2016
Nakamura K, Osada M, Iwasa T, Takahashi S, Takizawa N, Akahoshi K, Ochiai T, Nakamura N, Akiho H, Itaba S, Harada N, Iju M, Tanaka M, Kubo H, Somada S, Ihara E, Oda Y, Ito T, Takayanagi R.
Short- and long-term outcomes of endoscopic resection of rectal neuroendocrinetumors: analyses according to the WHO 2010 classification.
Scand J Gastroenterol 51: 448-455, 2016
Notohara K, Nishimori I, Mizuno N, Okazaki K, Ito T, Kawa S, Egawa S, Kihara Y, Kanno A, Masamune A, Shimosegaw T.
Clinicopathological Features of Type 2 Autoimmune Pancreatitis in Japan: Results of a Multicenter Survey.
Pancreas. 44: 1072-1077, 2015
Kawa S, Okazaki K, Notohara K, Ueki T, Matsui T, Kanno A, Watanabe T, Uchida K, Taguchi M, Igarashi H, Ito T, Igarashi H, Kawanobe T, Iijima H, Kohgo Y, Ito T, Kunisaki R, Nagahori M, Itoi T, Honjo M, Sakagami J, Yasuda H, Hatakeyama K, Iiai T, Hirooka Y, Sumi H, Watanabe K, Sasaki M, Ando A, Inatomi O, Kinjo F, Iraha A, Fujita N, Masu K, Kagaya T, Miyakawa H, Okamura K, Hibi N, Nakamura Y, Fukuda K, Ikeura T, Ishikawa T, Ueno F, Satoh A, Uemura M, Tsubouchi H, Funakawa K, Iizuka M, Yoden A, Kubota K, Funayama Y, Eguchi T, Ishigro Y, Uehara N, Arakura N, Kamisawa T, Nishimori I, Ohara H, Mizuno N, Hirano K, Masamune A, Kikuta K, Watanabe M, Shimosegawa T.
Autoimmune Pancreatitis Complicated with Inflammatory Bowel Disease and
Comparative Study of Type 1 and Type 2 Autoimmune Pancreatitis.
J Gastroenterol. 50: 805-815, 2015
Watanabe Y, Ohtsuka T, Matsunaga T, Kimura H, Tamura K, Ideno N, Aso T, Miyasaka Y, Ueda J, Takahata S, Igarashi H, Inoguchi T, Ito T, Tanaka M.
Long-Term Outcomes After Total Pancreatectomy: Special Reference to Survivors' Living Conditions and Quality of Life.
World J Surg. 39: 1231-1239, 2015
Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Yakano K, Komoto I, Tanaka M, Imamura M, Jensen RT, Takayanagi R, Shimatsu A.
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
J Gastroenterol.50: 58-64, 2015
Aoki T, Kokudo N, Komoto I, Takaori K, Kimura W, Sano K, Takamoto T, Hashimoto T, Okusaka T, Morizane C, Ito T, Imamura M.
Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of multi-center survey in Japan.
J Gastroenterol. 50: 769-775, 2015
Ito T, Lee L, Hijioka M, Kawabe K, Kato M, Nakamura K, Ueda K, Ohtsuka T, Igarashi H.
The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
J Hepatobiliary Pancreat Sci. 22: 574-547, 2015
Igarashi H, Hijioka M, Lee L, Ito T.
Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.
J Hepatobiliary Pancreat Sci. 22: 618-622, 2015
Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T.
Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine tumors:a single-center retrospective study.
Jpn J Clin Oncol. 45: 1131-1138, 2015
Hijioka M, Ito T, Igarashi H, Fujimori N, Lee L, Nakamura T, Jensen RT, Takayanagi R.
Serum Chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumor.
Cancer Sci. 105: 1464-1471, 2014
Niina Y, Ito T, Oono T, Nakamura T, Fujimori N, Igarashi H, Sakai Y, Takayanagi R.
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Pancreatology. 14:201-10. 2014
Ohtsuka T, Tamura K, Ideno N, Aso T, Nagayoshi Y, Kono H, Ueda J, Takahata S, Aso A, Igarashi H, Ito T, Ushijima Y, Ookubo F, Oda Y, Mizumoto K, Tanaka M.
The role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma.
Surg Today. 44: 1887-1892, 2014
Kamisawa T, Okazaki T, Kawa S, Shimosegawa T, Tanaka M, Nishimori I, Ito T, Tanaka S, and Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society.
Amendment of Japanese Consensus Guideline for Management of Autoimmune Pancreatitis,2013. III. Treatment and prognosis of AIP.
J Gastroenterol. 49: 961-970, 2014
Kawa S, Okazaki K, Kamisawa T, Kubo K, Ohara H, Hasebe O, Fujinaga Y, Irisawa A, Notohara K, Ito T, Inui K, Irie H, Nishino T, Nishimori I, Tanaka S, Nishiyama T, MD, Suda K, Shiratori K, Tanaka M, Shimosegawa T.
Amendment of Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013.II. Extra-pancreatic lesions, differential diagnosis.
J Gastroenterol. 49: 765-784, 2014
Okazaki T, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, Nishino T, Notohara K, Nishimori I, Tanaka S, Nishiyama T, Suda K, Shiratori K, Tanaka M, Shimosegawa T, and Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society.
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013.I. Concept and diagnosis of autoimmune pancreatitis.
J Gastroenterol. 49: 567-588, 2014
Uchida M, Ito T, Nakamura T, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Takayanagi R, Jensen RT.
Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas, acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.
Pancreas. 43: 708-719, 2014
Ishigami K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Fujita N, Takahata S, Ohtsuka T, Ito T, Igarashi H, Ikari S, Metz CM, Honda H.
Imaging pitfalls of pancreatic serous cystic neoplasm and its potential mimickers.
World J Radiol. 6: 36-47, 2014
Nagayoshi Y, Aso T, Ohtsuka T, Kono H, Ideno N, Igarashi H, Takahata S, Oda Y, Ito T, Tanaka M.
Peroral pancreatoscopy using the SpyGlass system for the assessment of Intraductal papillary mucinous neoplasm of the pancreas.
J Hepatobiliary Pancreat Sci. 21: 410-417, 2014
Aso A, Ihara E, Osoegawa T, Nakamura K, Itaba S, Igarashi H, Ito T, Aishima S, Oda Y, Tanaka M, Takayanagi R.
Key Endoscopic Ultrasound Features of Pancreatic Ductal Adenocarcinoma Smaller than 20 mm.
Scand J Gastroenterol. 49: 332-338, 2014
Nagayoshi Y, Nakamura M, Matsuoka K, Ohtsuka T, Mori Y, Kono H, Aso T, Ideno N, Takahata S, Ryo A, Takeda H, Ito T, Oda Y, Endo Y, Sawasaki T, Tanaka M.
Profiling of autoantibodies in sera of pancreatic cancer patients.
Ann Surg Oncol. 21: 459-465, 2014
Nakamura T, Ito T, Uchida M, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Jensen RT, Takayanagi R.
PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist.
Lab Invest. 94: 63-78, 2014
Igarashi H, Ito T, Nishimori I, Yamasaki I, Shuin T.
Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey.
J Gastroenterol. 49: 511-516, 2014
Fujimori N, Igarashi H, Asou A, Kawabe K, Lee L, Oono T, Nakamura T, Niina Y, Hijioka M, Uchida M, Kotoh K, Nakamura K, Ito T, Takayanagi R.
Endoscopic approach through the minor papilla in the management of pancreatic diseases.
World J Gastrointest Endosc. 5: 81-88, 2013
Uchida M, Ito T, Nakamura T, Igarashi H, Oono T, Fujimori N, Kawabe K, Suzuki K, Jensen RT, Takayanagi R.
ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells.
Lab Invest.93:41-53, 2013
Otsuki M, Takeda K, Matsuno S, Kihara Y, Koizumi M, Hirota M, Ito T, Kataoka K, Kitagawa M, Inui K, Takeyama Y.
Criteria for the diagnosis and severity stratification of acute pancreatitis.
World J Gastroenterol. 19: 5798-5805, 2013
Ohtsuka T, Ideno N, Aso T, Nagayoshi Y, Kono H, Mori Y, Takahata S, Oda Y, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.
Role of endoscopic retrograde pancreatography for early detection of Pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
J Hepatobiliary Pancreat Sci. 20: 356-361, 2013
Ito T, Okusaka T, Nishida T, Igarashi H, Mizuno N, Hara K, Morizane C, Kondo S, Hashigaki S, Kimura N, Okano K, Tanuma J, Murakami M, Sawaki A, Yamao K, Imamura M.
Phase II Study of Sunitinib in Japanese Patients with Unresectable or Metastatic, Well-differentiated Pancreatic Neuroendocrine Tumor.
Invest New Drugs. 31: 1265-1274, 2013
Ito T, Igarashi H, Uehara H, Berma MJ, Jense RT.
Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1 With Pancreatic Endocrine Tumor and Zollinger-Ellison Syndrome: Prospective Study of 106 Cases and Review of the Literature.
Medicine (Baltimore). 92: 135-181, 2013
Nakamura T, Ito T, Igarashi H, Uchida M, Hijioka M, Oono T, Fujimori N, Niina Y, Suzuki K, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as a damage-associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: a plausible mechanism for tissue injury-associated pancreatitis.
Int J Inflam.2:504128. 2012
Igarashi H, Ito T, Oono T, Nakamura T, Fujimori N, Niina Y, Hijioka M, Uchida M, Lee R, Iwao R, Nakamura K, Kotoh K, Takayanagi R.
Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
J Dig Dis.13:274-9, 2012
Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, Sadakari Y, Takahata S, Oda Y, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.
Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.
Am J Surg. 204: 44-48, 2012
Nakamura T, Ito T, Suzuki K, Uchida M, Igarashi H, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as damage-associated molecular-patters induced inflammatory responses in rat pancreatic stellate cells ~ plausible mechanism for tissue-injury associated pancreatitis.
Int J Inflam. 2012: 504128, 2012
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui K, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H for the All Japan IgG4 team.
Comprehensive Diagnostic Criteria (CDC criteria) for IgG4-related disease(IgG4-RD), 2011.
Mod Rheumatol. 22: 21-30, 2012
Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, Takahata S, Nakamura M, Ito T, Tanaka M.
Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
J Gastroenterol. 47: 678-685, 2012
Ito T, Okusaka T, Ikeda M, Igarashi H, Morizane C, Nakachi K, Tajima T, Kasuga A, Fujita Y, Furuse J.
Everolimus for Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial.
Jpn J Clin Oncol. 42: 903-911, 2012
Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K.
RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group.
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
N Engl J Med. 364: 514-523, 2011
Okusaka T, Furuse J, Funakoshi A, Ioka T, Yamao K, Ohkawa S, Boku N, Komatsu Y, Nakamori S, Iguchi H, Ito T, Nakagawa K, Nakachi K.
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer.
Cancer Sci. 102: 425-443, 2011
Fujimori N, Oono T, Igarashi H, Ito T, Nakamura T, Uchida M, Coy DH, Jensen RT, Takayanagi R.
Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.
Peptides. 32:2067-76, 2011
Nakamura T, Ito T, Oono T, Igarashi H, Fujimori N, Uchida M, Niina Y, Yasuda M, Suzuki K, Takayanagi R.
Bacterial DNA promotes proliferation of rat pancreatic stellate cells thorough toll-like receptor 9: potential mechanisms for bacterially induced fibrosis.
Pancreas. 40:823-31, 2011
Ito T, Nakamura T, Fujimori N, Niina Y, Igarashi H, Oono T, Uchida M, Kawabe K, Takayanagi R, Nishimori I, Otsuki M, Shimosegawa T.
Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
J Dig Dis. 12:210-6, 2011
Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M.
Epidemiological Study of Gastroenteropancreatic Neuroendocrine Tumors in Japan.
J Gastroenterol. 45: 234-243, 2010
Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T, Fujimori N, Oono T, Takayanagi R, Shimosegawa T.
Epidemiological Study of Pancreatic Diabetes in Japan in 2005: A Nationwide Study.
Pancreas. 39:829-835, 2010